drugset / Trial / NCT06592547

Intravenous Metoprolol in Septic Shock

NCT06592547

Phase 2 Completed 100 enrolled Alexandria University
RandomizedParallel-groupSingle-blindTreatment

Summary

A RCT designed to assess the effect of giving intravenous beta-blockers in patients with septic shock after achieving hemodynamic stability. The principle of this study is to control heart rate allowing for better diastolic filling and thus better perfusion.

Timeline

Start
2022-04-01
Primary completion
2023-12-01
Completion
2024-11-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoprolol Other / unclassified Intravenous